FI98459B - Menetelmä terapeuttisesti käyttökelpoisten 5-etano-2,3,4,5-1H-2-bentsatsepin-7-olikarbamaattijohdannaisten valmistamiseksi - Google Patents

Menetelmä terapeuttisesti käyttökelpoisten 5-etano-2,3,4,5-1H-2-bentsatsepin-7-olikarbamaattijohdannaisten valmistamiseksi

Info

Publication number
FI98459B
FI98459B FI920933A FI920933A FI98459B FI 98459 B FI98459 B FI 98459B FI 920933 A FI920933 A FI 920933A FI 920933 A FI920933 A FI 920933A FI 98459 B FI98459 B FI 98459B
Authority
FI
Finland
Prior art keywords
bentsazsepine
ethano
therapeutically useful
preparing therapeutically
preparing
Prior art date
Application number
FI920933A
Other languages
English (en)
Swedish (sv)
Other versions
FI920933A0 (fi
FI98459C (fi
Inventor
Yuhpyng L Chen
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of FI920933A0 publication Critical patent/FI920933A0/fi
Application granted granted Critical
Publication of FI98459B publication Critical patent/FI98459B/fi
Publication of FI98459C publication Critical patent/FI98459C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/22—Bridged ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
FI920933A 1989-08-30 1992-03-02 Menetelmä terapeuttisesti käyttökelpoisten 5-etano-2,3,4,5-1H-2-bentsatsepin-7-olikarbamaattijohdannaisten valmistamiseksi FI98459C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/US1989/003760 WO1991003467A1 (en) 1989-08-30 1989-08-30 Benzazabicyclic carbamates as novel cholinesterase inhibitors
US8903760 1989-08-30

Publications (3)

Publication Number Publication Date
FI920933A0 FI920933A0 (fi) 1992-03-02
FI98459B true FI98459B (fi) 1997-03-14
FI98459C FI98459C (fi) 1997-06-25

Family

ID=22215198

Family Applications (1)

Application Number Title Priority Date Filing Date
FI920933A FI98459C (fi) 1989-08-30 1992-03-02 Menetelmä terapeuttisesti käyttökelpoisten 5-etano-2,3,4,5-1H-2-bentsatsepin-7-olikarbamaattijohdannaisten valmistamiseksi

Country Status (8)

Country Link
US (1) US5387590A (fi)
EP (1) EP0415634A3 (fi)
JP (1) JPH0692373B2 (fi)
CA (1) CA2024162C (fi)
FI (1) FI98459C (fi)
IE (1) IE903122A1 (fi)
PT (1) PT95119B (fi)
WO (1) WO1991003467A1 (fi)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4713774B2 (ja) * 2001-07-10 2011-06-29 株式会社不二工機 切換弁
CN102712643B (zh) 2009-05-22 2015-12-16 Abbvie公司 5-ht受体的调节剂及其使用方法
EP2533645B1 (en) 2010-02-09 2016-07-27 The Johns Hopkins University Methods and compositions for improving cognitive function
WO2011146089A1 (en) 2010-05-21 2011-11-24 Abbott Laboratories Modulators of 5-ht receptors and methods of use thereof
JP6440625B2 (ja) 2012-11-14 2018-12-19 ザ・ジョンズ・ホプキンス・ユニバーシティー 精神分裂病を処置するための方法および組成物
EP2968220B1 (en) 2013-03-15 2021-05-05 Agenebio, Inc. Methods and compositions for improving cognitive function
EP2968237A4 (en) 2013-03-15 2016-08-31 Univ Johns Hopkins METHOD AND COMPOSITIONS FOR IMPROVING COGNITIVE FUNCTION
WO2015009742A2 (en) * 2013-07-15 2015-01-22 Board Of Regents, The University Of Texas System Compounds and methods for treating cancer, neurological disorders, ethanol withdrawal, anxiety, depression, and neuropathic pain
MX384391B (es) 2015-05-22 2025-03-14 Agenebio Inc Composiciones farmacéuticas de levetiracetam de liberación extendida.
US11046670B2 (en) 2015-10-19 2021-06-29 Board Of Regents, The University Of Texas System Piperazinyl norbenzomorphan compounds and methods for using the same
EP3448520A4 (en) 2016-04-29 2020-07-29 Board Of Regents, The University Of Texas System SIGMA RECEIVER BINDERS

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2126584A (en) 1937-01-16 1938-08-09 James W Small Coffeepot
US3345373A (en) * 1964-05-25 1967-10-03 Smith Kline French Lab 2-polymethylallyl-5, 9-dimethyl-6, 7-benzmorphans and derivatives
JPS50106985A (fi) * 1973-05-08 1975-08-22
JPS49134693A (fi) * 1973-05-08 1974-12-25
JPS5921866A (ja) * 1982-07-27 1984-02-03 松下電器産業株式会社 地下収納装置
PT77267B (en) * 1982-09-07 1986-03-21 Lilly Co Eli Improved process for preparing novel octahydrobenz <f> isoquinolines or compounds relating thereto
JPS5981990A (ja) * 1982-11-02 1984-05-11 Victor Co Of Japan Ltd カラ−映像信号記録装置及び記録再生装置
JPS6320817A (ja) * 1986-07-14 1988-01-28 マルコン電子株式会社 積層セラミツク部品の製造方法
US4791107A (en) * 1986-07-16 1988-12-13 Hoechst-Roussel Pharmaceuticals, Inc. Memory enhancing and analgesic 1,2,3,3A,8,8A-hexahydro-3A,8 (and) 1,3A,8)-di(and tri)methylpyrrolo(2,3-B)indoles, compositions and use
JPH0259522A (ja) * 1988-08-26 1990-02-28 Nippon Iyakuhin Kogyo Kk 悩代謝及び／又は精神症状改善剤
JP5921866B2 (ja) 2010-12-24 2016-05-24 花王株式会社 不織布
JP6320817B2 (ja) 2014-03-24 2018-05-09 日清食品ホールディングス株式会社 粒状物の供給装置及び供給方法

Also Published As

Publication number Publication date
IE903122A1 (en) 1991-03-13
EP0415634A3 (en) 1992-06-17
JPH0692373B2 (ja) 1994-11-16
PT95119B (pt) 1997-09-30
FI920933A0 (fi) 1992-03-02
CA2024162A1 (en) 1991-03-01
FI98459C (fi) 1997-06-25
CA2024162C (en) 1998-01-27
PT95119A (pt) 1991-05-22
EP0415634A2 (en) 1991-03-06
WO1991003467A1 (en) 1991-03-21
JPH03118366A (ja) 1991-05-20
US5387590A (en) 1995-02-07

Similar Documents

Publication Publication Date Title
NO176758C (no) Analogifremgangsmåte for fremstilling av terapeutiske anvendbare tetrazolyl-bifenylylmetyl-pyrimidiner
FI890282A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten 23,24-didehydro-25-hydroksikalsiferolijohdannaisten valmistamiseksi
NO176759C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 3-substituerte-2-oksindol-derivater
FI873350A7 (fi) Menetelmä terapeuttisesti käyttökelpoisten 1,4-dihydropyridiinijohdannaisten valmistamiseksi
FI883603A7 (fi) Menetelmä terapeuttisesti käyttökelpoisten 1,4-dihydropyridiinijohdannaisten valmistamiseksi
FI903752A7 (fi) Menetelmä 1,2,3,4-tetrahydro-9-akridiiniamiinin johdannaisten valmistamiseksi
PT87717A (pt) Process for preparing 2,4-thiazolidinedione derivatives
FI880467A7 (fi) Menetelmä terapeuttisesti käyttökelpoisten substituoitujen 3,4-dihydro-2H-bentsopyraanien valmistamiseksi
FI920196A0 (fi) Miljoevaenligare process foer blekning av lignocellulosamaterial.
FI98459B (fi) Menetelmä terapeuttisesti käyttökelpoisten 5-etano-2,3,4,5-1H-2-bentsatsepin-7-olikarbamaattijohdannaisten valmistamiseksi
FI940280L (fi) Menetelmä demetyyliepypodofyylilotoksiinin valmistamiseksi
FI891677L (fi) Menetelmä 4-demetoksidaunomysinonin valmistamiseksi
FI925260L (fi) Menetelmä terapeuttisesti käyttökelpoisten 6-amino-substituoitujen oktahydro-1,7,8-indolitsiinitriolijohdannaisten valmistamiseksi
IT9020580A0 (it) procedimento per la produzione
FI892946A7 (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten 2,3,4,5-tetrahydro-1H-3-bentsoatsepiinijohdannaisten valmistamiseksi
FI943778L (fi) Menetelmä 1,1-dikloori-1-fluorietaanin valmistamiseksi
FI893682L (fi) Menetelmä terapeuttisesti käyttökelpoisten 1,2,5-ditiatsosiinijohdannaisten valmistamiseksi
FI960332A0 (fi) Menetelmä substituoitujan 4,6-diamino-5-syanopyrinidiinien valmistamiseksi
FI903088A0 (fi) Process foer framstaellning av straengsprutade skumkroppar.
FI893900L (fi) Menetelmä -butyrobetaiinin valmistamiseksi
FI905445A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten 4-amidinokromaani- ja 4-amidinopyrano/3,2-c/pyridiinijohdannaisten valmistamiseksi
FI900296A7 (fi) Menetelmä esi-insuliinin valmistamiseksi
FI910159A7 (fi) Menetelmä uusien, terapeuttisesti käyttökelpoisten 9a-hydroksi-3-okso- 4,24(25)-stigmastadieeni-26-happojohdannaisten valmistamiseksi
FI911282L (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten 3,4-dihydroksi-2,5-dihydrofuranonien valmistamiseksi
FI891111A0 (fi) Menetelmä 1,4-dihydropyridiinijohdannaisten valmistamiseksi

Legal Events

Date Code Title Description
BB Publication of examined application
MA Patent expired